Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
The Pharmacogenomics Journal|November 30, 2005
(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean populationN Ballon, S Leroy, C Roy, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2000
Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorderA Galinowski, C Castelnau, O Spreux-Varoquaux, et al.Human Psychopharmacology|January 13, 2004
Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteersM F Poirier, A Galinowski, I Amado, et al.Neuroreport|March 10, 2001
Impairment of predictive saccades in schizophreniaM O Krebs, A Gut-Fayand, I Amado, et al.L'Encephale|March 18, 2003
[Cannabis and schizophrenia: demographic and clinical correlates]A Dervaux, X Laqueille, M-C Bourdel, et al.Neurophysiologie Clinique = Clinical Neurophysiology|December 1, 1991
[Quantified EEG in the diagnosis of Alzheimer's type dementia]B Gueguen, C Derouesné, M C Bourdel, et al.Psychiatry Research|June 29, 1995
Sensitive assay of thyroid stimulating hormone in depressed patientsM F Poirier, H Lôo, A Galinowski, et al.Psychopharmacology|December 14, 1999
Obsessive-compulsive disorder: evaluation of clinical and biological circadian parameters during fluoxetine treatmentB Millet, Y Touitou, M F Poirier, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1991
(99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer typeU Spampinato, M O Habert, J L Mas, et al.L'Encephale|September 15, 2009
[Homicide and major mental disorder: what are the social, clinical, and forensic differences between murderers with a major mental disorder and murderers without any mental disorder?]S Richard-Devantoy, A-S Chocard, M-C Bourdel, et al.Pageof 5